Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma

Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma

BackgroundIn a recently published retrospective case series, Temozolomide was found active as second line approach in advanced ACC patients. The disease control rate obtained, however, was short-lived. We report here an ACC patient with extensive metastatic disease who obtained a remarkable long las...

Full description

Bibliographic Details
Main Authors: Deborah Cosentini, Antonella Turla, Ornella Carminati, Salvatore Grisanti, Vittorio Domenico Ferrari, Marta Laganà, Giovanni Rosti, Sandra Sigala, Alfredo Berruti
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Endocrinology
Subjects:
adrenal tumor
alkylating drug
progesterone
treatment
ACC
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.674039/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.674039/full

Similar Items